RAPT Therapeutics Announces Pricing of Public Offering of
SOUTH SAN FRANCISCO, Calif., Nov. 17, 2022 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT) (“RAPT” or the “Company”), a clinical-stage,...
Stay updated with breaking news from Evercore Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SOUTH SAN FRANCISCO, Calif., Nov. 17, 2022 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT) (“RAPT” or the “Company”), a clinical-stage,...
/PRNewswire/ -- Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today announced the preliminary results of its Dutch...
Transaction will strengthen Lumen's financial position and sharpen strategic focus DENVER and LONDON, Nov. 3, 2022 /PRNewswire/ -- Lumen Technologies (NYSE: LUMN) and Colt Technology Services (Colt), a digital infrastructure company, announce today they have entered into an exclusive arrangement for the proposed sale of Lumen's Europe, Middle East and Africa (EMEA) business to Colt for $1.8 billion....
Transaction will strengthen Lumen's financial position and sharpen strategic focus DENVER and LONDON, Nov. 2, 2022 /PRNewswire/ -- Lumen Technologies (NYSE: LUMN) and Colt Technology Services
Lumen Technologies said it would sell its business across Europe, the Middle East and Africa to Colt for $1.8 billion. #pressrelease